MARKET

DXCM

DXCM

Dexcom Inc
NASDAQ
118.24
+1.62
+1.39%
After Hours: 119.00 +0.76 +0.64% 19:56 12/04 EST
OPEN
116.25
PREV CLOSE
116.62
HIGH
118.79
LOW
116.20
VOLUME
3.09M
TURNOVER
0
52 WEEK HIGH
139.55
52 WEEK LOW
74.75
MARKET CAP
45.68B
P/E (TTM)
133.91
1D
5D
1M
3M
1Y
5Y
Dexcom Inc: Statement of changes in beneficial ownership of securities
Press release · 16h ago
Community Health (CYH) Sells Three Florida Facilities for $294M
NASDAQ · 22h ago
Exact Sciences (EXAS) Up 35.4% YTD: Will the Rally Continue?
NASDAQ · 22h ago
Analyst Expectations for DexCom's Future
Dexcom has an average price target of $118.12 with a high of $145.00. 8 analysts have offered 12-month price targets for dexcom in the last 3 months. Dexcom has observed the following analyst ratings over the last quarter. The greater the number of bullish ratings, the more positive analysts are on the stock.
Benzinga · 1d ago
Morgan Stanley Maintains Equal-Weight on DexCom, Raises Price Target to $122
Benzinga · 1d ago
Thermo Fisher (TMO) Advances Health Equity via New Partnership
NASDAQ · 1d ago
BiomX (PHGE) Reports Positive Pulmonary Infection Treatment Data
NASDAQ · 1d ago
Weekly Report: what happened at DXCM last week (1127-1201)?
Weekly Report · 1d ago
More
About DXCM
DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for use by people with diabetes and by healthcare providers. Its Dexcom G6 is a CGM system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin dosing systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management. Its Dexcom Share remote monitoring system, offered for use with its Dexcom system, uses an application on the patient's mobile device to wirelessly transmit glucose information to the cloud and then to applications on the mobile devices of up to five designated recipients. Its Dexcom Real-Time API enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices. Its other products include Dexcom ONE and Dexcom G7.

Webull offers DexCom, Inc. stock information, including NASDAQ: DXCM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DXCM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DXCM stock methods without spending real money on the virtual paper trading platform.